A Phase 2 interventional study of Standard dialectical behavior therapy (SDBT) and Individual DBT with no DBT group sessions (DBT-I) in Borderline Personality Disorder and Suicide, sponsored by University of Washington. Completed at 1 site in United States. Open to female participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2012-02-02.
Sponsored by University of Washington · Phase 2, Interventional, and Treatment
This study is a component analysis of dialectical behavior therapy (DBT) to determine the importance of DBT skills training and DBT individual therapy in treating suicidal women with borderline personality disorder.
People with borderline personality disorder have limited behavioral skills and react abnormally to emotional stimulation. Standard dialectical behavior therapy (SDBT) has been shown to be an effective treatment for borderline personality disorder. This treatment combines weekly group sessions, at which patients learn new ways of dealing with their emotions, with weekly individual sessions with a therapist to discuss their emotions. The study compares SDBT to both individual DBT with no skills training and DBT skills training with no individual therapy. The study will determine whether efficacy of standard DBT is reduced when either DBT skills training or individual DBT therapy is removed.
Participants are randomly assigned to receive 1 year of SDBT, DBT with group sessions but no individual sessions, and DBT with individual sessions with no group sessions. Participants are monitored for 1 year after completing their assigned therapy. Throughout the 1-year study and during the 1-year follow-up period, self-report scales and questionnaires are used to assess participants every 4 months. These scales and questionnaires measure participants' suicidal thoughts and attempts, treatment compliance, emotional coping skills, social functioning, and overall well-being.
277 studies on the registry are indexed under Borderline Personality Disorder; 68 are open to participants now.
This study's enrollment of 99 is above the median of 70 across 222 interventional studies indexed under Borderline Personality Disorder.
Browse Borderline Personality Disorder studies →University of Washington is the lead sponsor of 1,431 studies on the registry; 226 are open to participants now.
Of its 158 completed or terminated interventional studies of FDA-regulated products, 136 (86%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants receive standard dialectical behavior therapy
Behavioral: Standard dialectical behavior therapy (SDBT)
Participants receive individual dialectical behavior therapy plus activities group
Behavioral: Individual DBT with no DBT group sessions (DBT-I)
Participants receive dialectical behavior therapy group skills plus case management
Behavioral: Group Skills DBT with no DBT individual sessions (DBT-S)
Standard DBT includes: 1) individual DBT therapy (1 hour per week), 2) DBT group skills training (2.5 hours per week), 3) telephone consultation (as needed), and 4) therapist consultation team (1 hour per week).
Also known as: DBT, SDBT
Individual DBT (DBT-I) is 1 hour per week of individual therapy and 2.5 hours per week with the psychosocial activities group.
Also known as: DBT, DBT-I
DBT group skills training is 2.5 hours per week and includes individual case management.
Also known as: DBT, DBT-S
Suicidal thoughts or attempts
Time frame: Measured at Year 2
Coping skills
Time frame: Measured at Year 2
The record gives a start of Apr 2004, a primary completion of Sep 2008 and a completion of Jun 2010. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Borderline Personality Disorder →